Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson’s Patients Using Digital Mobility Outcomes
Authors:
- Marco VicecontiMarco Viceconti
- Sabina Hernandez PennaSPSabina Hernandez Penna
- Wilhelmus DarteeWDWilhelmus Dartee
- Claudia MazzàClaudia Mazzà
- Brian CaulfieldBCBrian Caulfield
- Clemens BeckerCBClemens Becker
- Walter MaetzlerWMWalter Maetzler
- Judith Garcia-AymerichJGJudith Garcia-Aymerich
- Giorgio DavicoGDGiorgio Davico
- Lynn RochesterLRLynn Rochester
Open Access
Abstract
Wearable inertial sensors can be used to monitor mobility in real-world settings over extended periods. Although these technologies are widely used in human movement research, they have not yet been qualified by drug regulatory agencies for their use in regulatory drug trials. This is because the first generation of these sensors was unreliable when used on slow-walking subjects. However, intense research in this area is now offering a new generation of algorithms to quantify Digital Mobility Outcomes so accurate they may be considered as biomarkers in regulatory drug trials. This perspective paper summarises the work in the Mobilise-D consortium around the regulatory qualification of the use of wearable sensors to quantify real-world mobility performance in patients affected by Parkinson’s Disease. The paper describes the qualification strategy and both the technical and clinical validation plans, which have recently received highly supportive qualification advice from the European Medicines Agency. The scope is to provide detailed guidance for the preparation of similar qualification submissions to broaden the use of real-world mobility assessment in regulatory drug trials.Keywords
This publication has 52 references indexed in Scilit:
- Developing cloud applications using the e-Science Central platformPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2013
- Gait Speed and Survival in Older AdultsJAMA, 2011
- Development of a Clinical Measure of Dual-task Performance in WalkingJournal of Geriatric Physical Therapy, 2009
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Detection of walking periods and number of steps in older adults and patients with Parkinson's disease: accuracy of a pedometer and an accelerometry-based methodAge and Ageing, 2008
- Human movement analysis using stereophotogrammetryGait & Posture, 2005
- The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessmentMultiple Sclerosis Journal, 1999
- Dominance statistics: Ordinal analyses to answer ordinal questions.Psychological Bulletin, 1993
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- ParkinsonismNeurology, 1967